Status:
COMPLETED
The Effects of Acetaminophen on Fear
Lead Sponsor:
University of Guelph
Collaborating Sponsors:
Natural Sciences and Engineering Research Council, Canada
Conditions:
Fear
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study investigates the effects of acetaminophen on behavioral, physiological, and self-report fear responses.
Detailed Description
As acetaminophen blunts the experience of physical, social, and empathic pain, it is important to investigate whether there are other aversive states that the drug also provides relief from. If there ...
Eligibility Criteria
Inclusion
- 18 years or older
- Literate
- Speaks English
- Does not have any risk factors associated with acetaminophen (history of liver or kidney disease, taking other products with acetaminophen, has any allergies to acetaminophen, taking blood-thinning medications, drinks more than 12 alcoholic drinks per week for females, or more than 15 alcoholic drinks per week for males, are/ could be pregnant)
- Has taken acetaminophen in the past without any adverse reactions
- Is not diabetic
- Did not have anything to eat within three hours of study time
- Did not have any acetaminophen or alcohol in the 48 hours prior to study
- Has never had an adverse reaction to virtual reality before, such as headaches or nausea
Exclusion
- Younger than 18
- Non-literate
- Does not speak English
- Has at least one risk factor associated with acetaminophen (history of liver or kidney disease, taking other products with acetaminophen, has any allergies to acetaminophen, taking blood-thinning medications, drinks more than 12 alcoholic drinks per week for females, or more than 15 alcoholic drinks per week for males, are/ could be pregnant)
- Has never taken acetaminophen before
- Diabetic
- Had something to eat within three hours of scheduled study time
- Has had acetaminophen or alcohol in the past 48 hours
- Has had an adverse reaction to virtual reality in the past, such as headaches or nausea
Key Trial Info
Start Date :
March 30 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 12 2023
Estimated Enrollment :
266 Patients enrolled
Trial Details
Trial ID
NCT05396677
Start Date
March 30 2022
End Date
June 12 2023
Last Update
September 23 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Guelph
Guelph, Ontario, Canada, N1G 2W1